Congress

Dr. Medina

Assoc. Prof. Héctor Medina

Assoc. Prof. Héctor Medina Colombia Héctor Medina, MD, is a board certified cardiologist (by the American Board of Internal Medicine) working at Fundación Cardio-Infantil (FCI) in Bogotá Colombia and is an Assistant Professor of Medicine at El Rosario University. Also, he is the Director of the Advanced Cardiac Imaging Division and serves as the Cardiology…

Dr. Mueller

Dr. Matthias Mueller MD MSc

Dr. Matthias Mueller MD MSc Switzerland   Dr. Matthias Mueller MD MSc, Divisional Vice President Innovation and Development, Abbott’s Established Pharmaceuticals business Matthias Mueller heads Innovation and Development at Abbott’s Established Pharmaceuticals business. He leads a team of more than 1500 scientists and specialists worldwide that help deliver insight-driven, differentiated innovations to people in emerging…

Prof. Tommaso Simoncini

Prof. Tommaso Simoncini Italy Tommaso Simoncini is Professor of Obstetrics and Gynecology at the Department of Clinical and Experimental Medicine of the University of Pisa and Head of the OB/GYN Division. He has published over 290 original papers on high-impact scientific Journal, with a global IF of over 800 and an H index of 47.…

Dr. Schutte

Prof. Alta Schutte

Prof. Alta Schutte Australia SHARP Professor of Cardiovascular Medicine and Principal Theme Lead of Cardiac, Vascular and Metabolic Medicine at the University of New South Wales, and The George Institute for Global Health in Sydney, Australia. Professor Schutte’s research interest is the early detection, prevention and effective management of raised blood pressure or hypertension, where…

Dr. Klein

Dr. Pavel Klein

Dr. Pavel Klein United States Dr. Pavel Klein is the Director of the Mid-Atlantic Epilepsy and Sleep Center in Bethesda, MD. He is also Clinical Professor in the Department of Neurology at George Washington University in Washington, DC. Dr. Klein completed his medical degree at the University of Cambridge in Cambridge, UK, neurology residency and…

Olivier Gryson

Olivier Gryson, PharmD Switzerland Head of Digital Healthcare & a:care lead, Abbott, Switzerland. After studying pharmacy at the University of Paris V, Olivier GRYSON graduated in computer science applied to biology. He has worked for the last 20 years in the pharmaceutical industry in global positions, building international and local digital medical programs for healthcare…

Session: Improving medication adherence with motivational interviewing – example of a heart failure patient

Cardiovascular diseases are a perfect example of a chronic disease where motivational tools can improve adherence. For example, one in seven heart attack patients stop taking prescribed treatment one-month after receiving a stent which improves blood flow to the heart1,2. Understanding aspects of behavioral science, including Prochaska and Di Clemente’s Stages of Change Model, can help…

Session: End of Day 2

Speakers Prof. John Weinman Cem Arkilic, MD Chief Medical Officer Abbott, Switzerland Olivier Gryson

Session: Acting on the unseen: How do we help patients to remain adherent when they are asymptomatic?

Treatment non-adherence in patients can be associated with lack of symptoms, interference with daily schedule, lack of understanding of disease or treatment, or fear of stigma associated with disease1.  This is especially the case with conditions like hypertension where many patients can be asymptomatic. However, medication non-adherence is not without consequences and can increase a…

Session: The Global Challenge of medication adherence

Globally, it’s estimated that 30-50% of medicines prescribed for long-term illnesses are not taken as directed1. In this session, Professor John Weinman highlights key factors for non-adherence and how behavioral science, combined with digital tools, may help remedy this issue. Prof. Weinman emphasized the need to raise awareness of the depth of non-adherence to medicines…

Session: Introducing the my a:care motivational solution

my a:care is Abbott’s latest mobile application to support a patient’s adherence to medication through reminders, encouragement, and accountability, and by providing health information. my a:care app motivates behavior change by using attainable, measurable goals and easy to follow behavior changes rooted in established intervention methodology. Hear more about how my a:care app can improve a…

Session: Shhhh… avoiding acute crises in ‘silent disorders’

Medication adherence may be simple for acute, short-term diseases, but adherence becomes more difficult for chronic conditions when patients may not immediately realize the benefit of a treatment or intervention. Adherence is similarly difficult in patients with silent disorders, like hypertension, dyslipidemia or diabetes who are at risk of serious, life-threatening complications like stroke or heart…

Session: Principles of Anti-Microbial Resistance (AMR) stewardship and impact of adherence

With antimicrobials, non-adherence affects more than the individual patient1—it also drives treatment-resistant pathogens2. To keep antimicrobials alive, physicians must help their patients adhere to their medication, said Prof. Giamarellos-Bourboulis, who examined the barriers to antibiotic use and adherence and how to overcome them. To improve adherence, physicians must continue their education on the topic and leverage…

Session: The paradox of non-adherence in symptomatic disease

Though it’s easy to grasp why asymptomatic patients may be non-adherent, healthcare providers may be perplexed by non-adherence in patients who suffer from unpleasant symptoms. A 2021 study found that 45% of such patients were taking insufficient doses of their treatment despite experiencing symptoms ranging from irritating to incapacitating. “Adherence often goes unrecognized. We think…

Session: Behaviors and beliefs: the foundations of adherence

Adherence can vary between patients or within the same patient over time and across treatments1. Prof. Rob Horne emphasized that non-adherence is a variable behavior, not a trait cemented into a patient’s personality. Horne commented: “We assume if we inform the patient and if they have the correct knowledge, then action will follow, but 50%…